Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F

罗卡格拉特类药物诱导eIF4A和eIF4F的功能获得性改变

阅读:4
作者:Jennifer Chu ,Wenhan Zhang ,Regina Cencic ,Patrick B F O'Connor ,Francis Robert ,William G Devine ,Asher Selznick ,Thomas Henkel ,William C Merrick ,Lauren E Brown ,Pavel V Baranov ,John A Porco Jr ,Jerry Pelletier

Abstract

Rocaglates are a diverse family of biologically active molecules that have gained tremendous interest in recent years due to their promising activities in pre-clinical cancer studies. As a result, this family of compounds has been significantly expanded through the development of efficient synthetic schemes. However, it is unknown whether all of the members of the rocaglate family act through similar mechanisms of action. Here, we present a comprehensive study comparing the biological activities of >200 rocaglates to better understand how the presence of different chemical entities influences their biological activities. Through this, we find that most rocaglates preferentially repress the translation of mRNAs containing purine-rich 5' leaders, but certain rocaglates lack this bias in translation repression. We also uncover an aspect of rocaglate mechanism of action in which the pool of translationally active eIF4F is diminished due to the sequestration of the complex onto RNA. Keywords: eIF4A; eIF4F; interfacial inhibitor; rocaglates; translation initiation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。